The effect of ketoconazole on the pharmacokinetics and pharmacodynamics of inhaled fluticasone furoate and vilanterol trifenatate in healthy subjects.
about
Spotlight on fluticasone furoate/vilanterol trifenatate for the once-daily treatment of asthma: design, development and place in therapyKetoconazole-Associated Liver Injury in Drug-Drug Interaction Studies in Healthy Volunteers.Effect of severe renal impairment on umeclidinium and umeclidinium/vilanterol pharmacokinetics and safety: a single-blind, nonrandomized studyProfile of fluticasone furoate/vilanterol dry powder inhaler combination therapy as a potential treatment for COPDA repeat-dose thorough QT study of inhaled fluticasone furoate/vilanterol combination in healthy subjectsMetabolic considerations of drugs in the treatment of allergic diseases.Combination of fluticasone furoate and vilanterol for the treatment of chronic obstructive pulmonary disease.Fluticasone furoate/vilanterol: a review of its use in chronic obstructive pulmonary disease.Fluticasone furoate/vilanterol: a review of its use in patients with asthma.The combination of fluticasone furoate and vilanterol trifenatate in the management of asthma: clinical trial evidence and experience.Vilanterol trifenatate for the treatment of COPD.Pharmacodynamic and pharmacokinetic assessment of fluticasone furoate + vilanterol for the treatment of asthma.Fluticasone furoate and vilanterol trifenatate combination therapy for the treatment of asthma.The pharmacodynamics, pharmacokinetics, safety and tolerability of inhaled fluticasone furoate and vilanterol administered alone or simultaneously as fluticasone furoate/vilanterol.
P2860
Q28074802-BF25BFA4-45BE-4CA7-9931-ED3F0DFE33BDQ34511634-E86E984B-C132-4352-8729-BF2254265131Q34787196-7F17FC1E-4856-46CC-ABA4-A028B9B9FC9BQ37614090-CD4C7FC5-2894-483B-BE09-16BD072CA054Q37635200-FEC8246D-D16E-42F9-8634-5EA540E85280Q38125525-CCD3F103-C3B0-4848-9A85-B736277DAAB2Q38164675-005C26FE-68BE-4E67-BF1D-47D88B5E4FF0Q38235191-AFE1147C-2C27-4901-B7AC-0B0766EA7911Q38342870-92D1EBF8-F572-426A-AD29-DA069BE958D4Q38669520-3FC2AC0F-5012-4226-A0FA-6531DC804B08Q38824916-20DFC8EE-2C2E-4169-90B6-5E4A82A62D70Q38851423-6E7AAE43-16EA-4C92-A605-32C9F210979AQ40661319-A0B7C3DF-95D9-47F5-B146-48D3DC4D8F67Q51671642-4AC05B81-9BF0-4BE6-80B7-E63176A08BCC
P2860
The effect of ketoconazole on the pharmacokinetics and pharmacodynamics of inhaled fluticasone furoate and vilanterol trifenatate in healthy subjects.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The effect of ketoconazole on ...... ifenatate in healthy subjects.
@ast
The effect of ketoconazole on ...... ifenatate in healthy subjects.
@en
The effect of ketoconazole on ...... ifenatate in healthy subjects.
@nl
type
label
The effect of ketoconazole on ...... ifenatate in healthy subjects.
@ast
The effect of ketoconazole on ...... ifenatate in healthy subjects.
@en
The effect of ketoconazole on ...... ifenatate in healthy subjects.
@nl
prefLabel
The effect of ketoconazole on ...... ifenatate in healthy subjects.
@ast
The effect of ketoconazole on ...... ifenatate in healthy subjects.
@en
The effect of ketoconazole on ...... ifenatate in healthy subjects.
@nl
P2093
P2860
P356
P1476
The effect of ketoconazole on ...... ifenatate in healthy subjects.
@en
P2093
David Rubin
Joanne Bal
Rodger Kempsford
P2860
P304
P356
10.1111/BCP.12019
P407
P577
2013-06-01T00:00:00Z